Stephen Gordon, Chief Financial Officer at TransMedics Group, Inc. (TMDX), sold 29,345 shares at $141.27 ($4.1M) on 2024-05-29, disclosed to the SEC on 2024-05-31.
Open-market sale of $4.1M TMDX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $141.06 | 9,345 | $1.3M | 31.8% |
| 2 | $141.06 | 9,345 | $1.3M | 31.8% |
| 3 | $141.27 | 2,000 | $283K | 6.8% |
| 4 | $141.80 | 8,655 | $1.2M | 29.6% |
| Total | $141.29 avg | 29,345 | $4.1M | 100% |
| Filing → |
| TMDX | SELL | 2024-04-02 | $1.1M | — | Filing → |
| TMDX | SELL | 2024-03-12 | $334K | — | Filing → |
| TMDX | SELL | 2024-03-05 | $1.2M | — | Filing → |